Patents by Inventor Yosefa Avraham

Yosefa Avraham has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of hepatic encephalopathy and liver cirrhosis
    Patent number: 10166202
    Abstract: The compounds D9-tetrahydrocannabinol (THC), cannabidiol (CBD) and capsaicin are useful for prevention, treatment, or both, of hepatic encephalopathy. The compounds capsaicin, 2-arachidonoylglycerol (2-AG), HU-308 and cannabidiol are useful for prevention, treatment, or both, of liver cirrhosis.
    Type: Grant
    Filed: June 16, 2011
    Date of Patent: January 1, 2019
    Assignees: Yissum Research Development Company of the Hebrew University of Jerusalem, Hadasit Medical Research Services & Development Ltd., Aristotle University of Thessaloniki
    Inventors: Elliot Berry, Yosefa Avraham, Raphael Mechoulam, Yaron Ilan, Yossi Dagon, Iddo Magen, Nicholas Grigoriadis, Theofilos Poutachidis
  • Compounds and methods of treating obesity
    Patent number: 9428448
    Abstract: Provided are new fatty acid derivatives, methods for their preparation, pharmaceutical compositions including such compounds, and methods of using these compounds and compositions, e.g., as agents for the treatment of obesity and related disorders, and for improving cognition.
    Type: Grant
    Filed: June 25, 2014
    Date of Patent: August 30, 2016
    Assignees: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., Al-Quds University
    Inventors: Jehoshua Katzhendler, Meir Saidian, Yousef Najajreh, Raphael Mevorach, Elliot Berry, Yosefa Avraham
  • Compounds for improving nutritional status, cognition and survival
    Patent number: 9333240
    Abstract: The present invention concerns using a leptin protein, a variant fragment or mimic of a leptin protein, or an activator of the AMPK signal transduction pathway for preparing a medicament that can either be used to improve cognitive function or to treat treatment of undesirable manifestations of a nutritional stress condition and to prolong survival.
    Type: Grant
    Filed: September 14, 2006
    Date of Patent: May 10, 2016
    Assignee: YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD.
    Inventors: Elliot Berry, Yosefa Avraham, Yossi Dagon
  • FATTY ACID DERIVATIVES FOR USE IN A METHOD OF TREATING DEPRESSION AND ASSOCIATED CONDITIONS
    Publication number: 20150202179
    Abstract: The invention provides fatty acid derivatives for use in a method of treatment of at least one disease, disorder or condition selected from anxiety, depression, conditions associated menopause, stress, bipolar disorder, neuropathic pain and fibromyalgia.
    Type: Application
    Filed: July 21, 2013
    Publication date: July 23, 2015
    Inventors: Elliot Berry, Yosefa Avraham, Joshua Katzhendler, Josef Mograbi, Yousef Najajreh, Lia Vorobeiv
  • COMPOUNDS AND METHODS OF TREATING OBESITY
    Publication number: 20140309273
    Abstract: Provided are new fatty acid derivatives, methods for their preparation, pharmaceutical compositions including such compounds, and methods of using these compounds and compositions, e.g., as agents for the treatment of obesity and related disorders, and for improving cognition.
    Type: Application
    Filed: June 25, 2014
    Publication date: October 16, 2014
    Applicants: YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD., AL-QUDS UNIVERSITY
    Inventors: Jehoshua KATZHENDLER, Meir SAIDIAN, Yousef NAJAJREH, Raphael MEVORACH, Elliot BERRY, Yosefa AVRAHAM
  • TREATMENT OF HEPATIC ENCEPHALOPATHY AND LIVER CIRRHOSIS
    Publication number: 20110251290
    Abstract: The compounds D9-tetrahydrocannabinol (THC), cannabidiol (CBD) and capsaicin are useful for prevention, treatment, or both, of hepatic encephalopathy. The compounds capsaicin, 2-arachidonoylglycerol (2-AG), HU-308 and cannabidiol are useful for prevention, treatment, or both, of liver cirrhosis.
    Type: Application
    Filed: June 16, 2011
    Publication date: October 13, 2011
    Applicants: Yissum Research Development Company of the Hebrew University of Jerusalem, Aristotle University of Thessaloniki, Hadasit Medical Research Services & Development Ltd.
    Inventors: Elliot BERRY, Yosefa Avraham, Raphael Mechoulam, Yaron Ilan, Yossi Dagon, Iddo Magen, Nicholas Grigoriadis, Theofilos Poutachidis
  • COMPOUNDS AND METHODS OF TREATING OBESITY
    Publication number: 20110178151
    Abstract: The present invention relates to novel fatty acid derivatives, methods for their preparation, pharmaceutical compositions including such compounds, and methods of using these compounds and compositions, especially as agents for the treatment of obesity and related disorders, and for improving cognition.
    Type: Application
    Filed: March 4, 2009
    Publication date: July 21, 2011
    Applicant: YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW
    Inventors: Jehoshua Katzhendler, Elliot Berry, Yosefa Avraham, Yousef Najajreh, Meir Saidian, Raphael Mevorach
  • Treatment of hepatic encephalopathy and liver cirrhosis
    Publication number: 20100022631
    Abstract: The compounds D9-tetrahydrocannabinol (THC), cannabidiol (CBD) and capsaicin are useful for prevention, treatment, or both, of hepatic encephalopathy. The compounds capsaicin, 2-arachidonoylglycerol (2-AG), HU-308 and cannabidiol are useful for prevention, treatment, or both, of liver cirrhosis.
    Type: Application
    Filed: April 24, 2009
    Publication date: January 28, 2010
    Applicants: Yissum Research Development Company of the Hebrew University of Jerusalem, Hadasit Medical Research Services & Development Ltd., Aristotle University of Thessaloniki
    Inventors: Elliot BERRY, Yosefa Avraham, Raphael Mechoulam, Yaron Ilan, Yossi Dagon, Iddo Magen, Nicholas Grigoriadis, Theofilos Poutachidis
  • Compounds for Improving Nutritional Status, Cognition and Survival
    Publication number: 20090175841
    Abstract: The present invention concerns using a leptin protein, a variant fragment or mimic of a leptin protein, or an activator of the AMPK signal transduction pathway for preparing a medicament that can either be used to improve cognitive function or to treat treatment of undesirable manifestations of a nutritional stress condition and to prolong survival.
    Type: Application
    Filed: September 14, 2006
    Publication date: July 9, 2009
    Inventors: Elliot Berry, Yosefa Avraham, Yossi Dagon